| Literature DB >> 31366621 |
Haijiao Zhang1,2, Beth Wilmot3, Daniel Bottomly3, Kim-Hien T Dao2, Emily Stevens4, Christopher A Eide2,5, Vishesh Khanna2,5, Angela Rofelty1,2, Samantha Savage1,2, Anna Reister Schultz1,2, Nicola Long1,2, Libbey White3, Amy Carlos6, Rachel Henson6, Chenwei Lin6, Robert Searles6, Robert H Collins7, Daniel J DeAngelo8, Michael W Deininger9, Tamara Dunn10, Than Hein9, Marlise R Luskin8, Bruno C Medeiros10, Stephen T Oh11, Daniel A Pollyea12, David P Steensma8, Richard M Stone8, Brian J Druker2,5, Shannon K McWeeney3, Julia E Maxson2, Jason R Gotlib10, Jeffrey W Tyner1,2.
Abstract
Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) are a group of rare and heterogeneous myeloid disorders. There is strong morphologic resemblance among these distinct diagnostic entities as well as a lack of specific molecular markers and limited understanding of disease pathogenesis, which has made diagnosis challenging in certain cases. The treatment has remained empirical, resulting in dismal outcomes. We, therefore, performed whole-exome and RNA sequencing of these rare hematologic malignancies and present the most complete survey of the genomic landscape of these diseases to date. We observed a diversity of combinatorial mutational patterns that generally do not cluster within any one diagnosis. Gene expression analysis reveals enrichment, but not cosegregation, of clinical and genetic disease features with transcriptional clusters. In conclusion, these groups of diseases represent a continuum of related diseases rather than discrete diagnostic entities.Entities:
Mesh:
Year: 2019 PMID: 31366621 PMCID: PMC6742922 DOI: 10.1182/blood.2019000611
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476